Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Comparative study of the efficacy of limaprost and pregabalin as single agents and in combination for the treatment of lumbar spinal stenosis: a prospective, double blind, randomized controlled non-inferiority trial.
Is cervical decompression beneficial in patients with coexistent cervical stenosis and multiple sclerosis?
Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.
A 3meter Timed Tandem Walk is an early marker of motor and cerebellar impairment in fully ambulatory MS patients.
Brachial plexus atrophy in chronic inflammatory demyelinating polyradiculoneuropathy.
Tumefactive multiple sclerosis and fingolimod: Immunotherapies and unintended consequences.
Oral therapy approved for multiple sclerosis.
Increased Circulating Levels of Vitamin D Binding Protein in MS Patients.
Tau protein levels in the cerebrospinal fluid of the patients with multiple sclerosis in an attack period: Low levels of tau protein may have significance, too.
Translating Neurogenomics into New Medicines.
Whole-brain atrophy: ready for implementation into clinical decision-making in multiple sclerosis?
Dietary Vitamin D and Its Metabolites Non-Genomically Stabilize the Endothelium.
Optimal detection of infratentorial lesions with a combined dual-echo MRI sequence: "PT2".
The effect of disease-modifying therapies on brain atrophy in patients with clinically isolated syndrome: a systematic review and meta-analysis.
Erratum to: Disentangling Multiple Sclerosis and depression: an adjusted depression screening score for patient-centered care.
Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings.
Acute Bilateral Optic Neuritis in Active Ankylosing Spondylitis.
[Epidemiology of neuromyelitis optica].
Extracellular Membrane Vesicles as Vehicles for Brain Cell-to-Cell Interactions in Physiological as well as Pathological Conditions.
Radiologically Isolated Syndrome in a Pediatric Patient.
B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions.
Salvianolic acid B ameliorates CNS autoimmunity by suppressing Th1 responses.
Laquinimod, an upcoming oral immunomodulatory agent for treatment of multiple sclerosis.
Social support and depressive symptoms among caregivers of veterans with multiple sclerosis.
SNPsea: an algorithm to identify cell types, tissues, and pathways affected by risk loci.
Pages
« first
‹ previous
…
633
634
635
636
637
638
639
640
641
…
next ›
last »